WHO says nasal vaccines could help control Covid

GENEVA Nasal Covid-19 vaccinations could aid in bringing the Covid-19 pandemic under control according to the World Health Organization said Wednesday after the approval of home-grown products in India as well as China.

The WHO has welcomed the latest face in the fight against the disease, however, it said it wants to examine the evidence about the vaccines in order in order to decide if it was appropriate to approve the vaccines.

China on Sunday unveiled the the first breath-able COVID vaccinecalled Convidecia Air, which is produced through CanSino Biologics and administered through an inhaler.

And India has approved a COVID-19 nasal vaccine for use in emergencies on Tuesday. It was created by Bharat Biotech.

Read more about: India has approved its very first nasal vaccine against COVID-19

WHO emergency Director Mike Ryan said nasal vaccines created immune responses within the respiratory mucosa of the lungs.

“You’re generating the first line of defence at where the virus enters and causes a lot of damage,” he said.

By doing this the nasal vaccines can stop a person from becoming infected and transmitting the virus to others.

Ryan explained the ways that nasal and injectable vaccines are combined to fight off diseases like polio, providing complete protection to the body’s internal systems.

This chance to cut down on the severity of the infection as well as the spreading “may offer us a much stronger prospect of control of COVID in the long run” said he at an event for press.

He advocated for innovation that could create a third and a fourth version of the vaccine “that we may need ultimately to deal with the end of COVID and to deal with future respiratory virus threats”.

Read more about: China approves the world’s very first COVID-19 inhalable vaccine

Maria Van Kerkhove, the WHO’s technical director for COVID-19 The WHO’s technical lead for COVID-19, greeted the news with.

“We look forward to seeing the data to see how this could be incorporated into the response for COVID-19,” she added.

CanSino as well as Bharat Biotech both have COVID-19 vaccines that are approved by WHO.

Mariangela Simao, the WHO’s access to vaccines head, confirmed that neither of the manufacturers had requested the WHO’s stamp of approval the latest products.

Other companies are working on nasal vaccines She added.

The death rate is every 44 seconds.

WHO head Tedros Adhanom Ghebreyesus has said that the continued decline in the number of reported COVID deaths and cases was encouraging, but he added that it would be “dangerous” to assume those trends will continue to be the case.

“Last week, one person died with COVID-19 every 44 seconds. Most of those deaths are avoidable,” the doctor said.

“You might be tired of hearing me say the pandemic is not over. But I will keep saying it until it is.”

Learn more here: UK approves Pfizer bivalent Covid vaccine prior to booster drive

Van Kerkhove stated that it may not be predicted yet that the virus that causes COVID-19, SARS-CoV-2, disease would be able to settle to a seasonal pattern.

This Omicron variation’s BA.5 subvariant has become dominant, however a variety of subvariants are in circulation.

You may also like...

Leave a Reply

Your email address will not be published.

%d bloggers like this: